Vietnam’s pharmaceutical industry is experiencing significant growth, presenting a lucrative opportunity for global companies. This article delves into the market dynamics, highlighting the substantial market size driven by a population of over 98 million and a high health insurance coverage rate. It also explores the challenges faced by domestic suppliers, such as limited R&D infrastructure and manufacturing capacity, and the dominance of nonprescription products. Discover how international players can leverage their expertise to tap into Vietnam’s high-margin innovative and branded drugs market.